ticlopidine has been researched along with Esophageal Neoplasms in 2 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
Esophageal Neoplasms: Tumors or cancer of the ESOPHAGUS.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Scholl, S | 1 |
Dellon, ES | 1 |
Shaheen, NJ | 1 |
Greenspan, NR | 1 |
2 other studies available for ticlopidine and Esophageal Neoplasms
Article | Year |
---|---|
Treatment of GERD and proton pump inhibitor use in the elderly: practical approaches and frequently asked questions.
Topics: Adenocarcinoma; Adult; Age Distribution; Age Factors; Aged; Aged, 80 and over; Aspirin; Barrett Esop | 2011 |
Gastroesophageal reflux disease: endoscopy, duration of treatment, and choice of PPI.
Topics: Adenocarcinoma; Clopidogrel; Drug Industry; Drug Interactions; Endoscopy, Gastrointestinal; Esophage | 2011 |